Characterising the genomic landscape of two clinical risk groups in CD30+ T-cell lymphoproliferative disorders with cutaneous involvement: a multi-institutional retrospective study.

Biral LPA, Russell V, Selim MA, Roth C, Love C, Shingleton J, Owusu D, Batra A, Mason EF, Kovach A, Amador C, Koff JL, Jaye D, Cheng CL, Evans A, Pillai R, Leppä S, Hsi ED, Ondrejka S, McKinney M, McCall CM, Bettoney S, Sojitra P, Evens A, Behdad A, Galvez C, Fedoriw Y, Thacker E, Thakkar D, Parker C, Happ L, Czader M, Gulati R, Naresh KN, Dave SS, Wang J

Open source

DOI
10.1016/j.ebiom.2026.106532
Published
2026 Oct 27
Container
EBioMedicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ebiom.2026.106532,
  title = {Characterising the genomic landscape of two clinical risk groups in CD30+ T-cell lymphoproliferative disorders with cutaneous involvement: a multi-institutional retrospective study.},
  author = {Biral LPA and Russell V and Selim MA and Roth C and Love C and Shingleton J and Owusu D and Batra A and Mason EF and Kovach A and Amador C and Koff JL and Jaye D and Cheng CL and Evans A and Pillai R and Leppä S and Hsi ED and Ondrejka S and McKinney M and McCall CM and Bettoney S and Sojitra P and Evens A and Behdad A and Galvez C and Fedoriw Y and Thacker E and Thakkar D and Parker C and Happ L and Czader M and Gulati R and Naresh KN and Dave SS and Wang J},
  year = {2026},
  journal = {EBioMedicine},
  doi = {10.1016/j.ebiom.2026.106532},
  url = {https://doi.org/10.1016/j.ebiom.2026.106532}
}

RIS

TY  - JOUR
TI  - Characterising the genomic landscape of two clinical risk groups in CD30+ T-cell lymphoproliferative disorders with cutaneous involvement: a multi-institutional retrospective study.
AU  - Biral LPA
AU  - Russell V
AU  - Selim MA
AU  - Roth C
AU  - Love C
AU  - Shingleton J
AU  - Owusu D
AU  - Batra A
AU  - Mason EF
AU  - Kovach A
AU  - Amador C
AU  - Koff JL
AU  - Jaye D
AU  - Cheng CL
AU  - Evans A
AU  - Pillai R
AU  - Leppä S
AU  - Hsi ED
AU  - Ondrejka S
AU  - McKinney M
AU  - McCall CM
AU  - Bettoney S
AU  - Sojitra P
AU  - Evens A
AU  - Behdad A
AU  - Galvez C
AU  - Fedoriw Y
AU  - Thacker E
AU  - Thakkar D
AU  - Parker C
AU  - Happ L
AU  - Czader M
AU  - Gulati R
AU  - Naresh KN
AU  - Dave SS
AU  - Wang J
PY  - 2026
JO  - EBioMedicine
DO  - 10.1016/j.ebiom.2026.106532
UR  - https://doi.org/10.1016/j.ebiom.2026.106532
ER  - 

APA

LPA, B., V, R., MA, S., C, R., C, L., J, S., D, O., A, B., EF, M., A, K., C, A., JL, K., D, J., CL, C., A, E., R, P., S, L., ED, H., S, O., M, M., CM, M., S, B., P, S., A, E., A, B., C, G., Y, F., E, T., D, T., C, P., L, H., M, C., R, G., KN, N., SS, D., & J, W. (2026). Characterising the genomic landscape of two clinical risk groups in CD30+ T-cell lymphoproliferative disorders with cutaneous involvement: a multi-institutional retrospective study.. EBioMedicine. https://doi.org/10.1016/j.ebiom.2026.106532

Source records